In this perspective, S. Louis Bridges Jr, MD, PhD, provides insight into managing care for patients with rheumatic diseases during the COVID-19 pandemic.
Effective and affordable treatment options are essential to controlling costs within the rheumatoid arthritis treatment space and delivering value to patients.
If physicians have a genuine interest in acting with beneficence and nonmaleficence, they should recognize that their prescribing habits have significant consequences for their patients.
The use of scribes has garnered a generally positive research base for being effective in improving clinician satisfaction, productivity, and physician-patient interactions.